|
NDUFS4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.758900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.124000E-01 |
| Normal-vs-Stage2 |
6.345200E-01 |
| Normal-vs-Stage3 |
1.56112999999403E-05 |
| Normal-vs-Stage4 |
4.04909999995873E-06 |
| Stage1-vs-Stage2 |
9.782200E-01 |
| Stage1-vs-Stage3 |
7.91610000000498E-05 |
| Stage1-vs-Stage4 |
8.1361000000002E-05 |
| Stage2-vs-Stage3 |
1.156260E-02 |
| Stage2-vs-Stage4 |
5.756600E-03 |
| Stage3-vs-Stage4 |
7.372200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.635500E-04 |
| Normal-vs-AfricanAmerican |
5.642800E-01 |
| Normal-vs-Asian |
7.764400E-02 |
| Caucasian-vs-AfricanAmerican |
2.063800E-01 |
| Caucasian-vs-Asian |
1.797650E-01 |
| AfricanAmerican-vs-Asian |
8.002100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.484800E-03 |
| Normal-vs-Female |
7.499500E-03 |
| Male-vs-Female |
8.943000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.420340E-02 |
| Normal-vs-Age(41-60Yrs) |
1.76108999999647E-05 |
| Normal-vs-Age(61-80Yrs) |
1.486360E-01 |
| Normal-vs-Age(81-100Yrs) |
8.765800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.255400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.068030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.140200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.325810E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.528400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.901000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.499800E-01 |
| Normal-vs-Grade 2 |
2.588600E-01 |
| Normal-vs-Grade 3 |
1.077500E-02 |
| Normal-vs-Grade 4 |
1.84030013450354E-10 |
| Grade 1-vs-Grade 2 |
9.132600E-01 |
| Grade 1-vs-Grade 3 |
3.277800E-01 |
| Grade 1-vs-Grade 4 |
3.859700E-03 |
| Grade 2-vs-Grade 3 |
1.192380E-01 |
| Grade 2-vs-Grade 4 |
3.59810004013639E-09 |
| Grade 3-vs-Grade 4 |
7.52160000000446E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.702400E-01 |
| Normal-vs-ccB subtype |
2.6574000000501E-06 |
| ccA subtype-vs-ccB subtype |
6.00530000000044E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.138300E-03 |
| Normal-vs-N1 |
5.198700E-04 |
| N0-vs-N1 |
2.273900E-02 |
|
|
